Abstract：
BACKGROUND AND OBJECTIVE:Several cases of facial paralysis have been reported following influenza vaccination; however, recent surveillance studies have not shown an increased risk. In this study, we analyzed the vaccine adverse event reporting system (VAERS) data to determine whether the facial paralysis reporting rate is higher in those who received influenza vaccination compared with those who received other vaccines. METHODS:We evaluated reports of facial paralysis in people who received influenza vaccination during January 2015 to October 2019 using Medical Dictionary for Regulatory Activities Preferred Terms. A disproportionality analysis was performed to determine the proportional reporting ratio (PRR), Chi-square statistic, and reporting odds ratio (ROR) with 95% confidence interval (CI). The demographic and clinical characteristics of the cases were also analyzed. RESULTS:Two hundred fifty cases of facial paralysis following influenza vaccination were reported during the study period. The median age of the patients was 45 (interquartile range, 30-57) years; 132 (52.8%) patients were females. The majority of the patients received the injected trivalent or quadrivalent seasonal influenza vaccine by intramuscular route. The PRR, Chi-square statistic, and ROR (95% CI) was 2.44, 122.32, and 2.44 (2.08-2.88), respectively; on excluding cases involving concomitant paresis/paralysis of limbs or Guillain-Barre syndrome, the disproportionality statistics were 2.30, 89.37, and 2.30 (1.93-2.75), respectively. CONCLUSIONS:Our study shows increased reporting of facial paralysis following influenza vaccination as compared with other vaccines. Considering the inherent limitations of the VAERS database analysis, and the fact that disproportionality measures only indicate the presence of a signal, our study findings need to be explored in well-designed prospective pharmacoepidemiologic studies.
journal_name
Clin Drug Investigjournal_title
Clinical drug investigationauthors
Kamath A,Maity N,Nayak MAdoi
10.1007/s40261-020-00952-0subject
Has Abstractpub_date
2020-09-01 00:00:00pages
883-889issue
9eissn
1173-2563issn
1179-1918pii
10.1007/s40261-020-00952-0journal_volume
40pub_type
杂志文章abstract：BACKGROUND AND OBJECTIVE:Schizophrenia treatment has been shifting to resocialization by efficacious antipsychotic drugs. However, even some of the pivotal studies of approved new antipsychotic drugs with proven efficacy had failed due to high placebo response. The aim of this study was to identify the potential factor...
journal_title：Clinical drug investigation
pub_type： 杂志文章,meta分析
doi：10.1007/s40261-018-0661-1
更新日期：2018-08-01 00:00:00
abstract：:Doravirine (MK-1439) is a novel non-nucleoside reverse transcriptase inhibitor indicated for the combination treatment of human immunodeficiency virus type-1 (HIV-1) infection. The recommended dose is 100 mg once daily. This review summarizes the pharmacokinetics of doravirine, the influence of intrinsic factors, and ...
journal_title：Clinical drug investigation
pub_type： 杂志文章,评审
doi：10.1007/s40261-020-00934-2
更新日期：2020-10-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Characteristics of nucleoside reverse transcriptase inhibitors (NRTIs) make the drug class susceptible to elimination via continuous veno-venous hemofiltration (CVVH), potentially leading to suboptimal drug concentrations if given at the recommended anephric doses during CVVH. The objective of ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-015-0275-9
更新日期：2015-04-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:First-line treatment of chronic phase (CP) chronic myeloid leukemia (CML) is based on the first-generation tyrosine kinase inhibitor (TKI) imatinib or the second-generation TKIs dasatinib or nilotinib. Thanks to the efficacy of TKIs, CML has switched from a fatal to a 'chronic' pathology, and ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-018-0676-7
更新日期：2018-09-01 00:00:00
abstract：:Epilepsy is common in children and adolescents where its prevalence is 3.2-5.5/1000. About one-third of patients also have attention deficit hyperactivity/impulsivity disorder (ADHD). The possible relationship between epilepsy and ADHD is still unclear, and ADHD symptoms (such as inattention, hyperactivity, behavioral...
journal_title：Clinical drug investigation
pub_type： 杂志文章,评审
doi：10.1007/s40261-017-0585-1
更新日期：2018-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:Statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) are unrelated. Many patients initiated on statins experience a paradoxical decrease in HDL-C. The aim of this study was to evaluate the association between a decrease in HDL-C...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-015-0372-9
更新日期：2016-03-01 00:00:00
abstract：BACKGROUND:Concomitant chemotherapy with radiotherapy is considered to be the standard of care for patients with head and neck cancer and good performance status. However, published reports on the cost effectiveness of this therapeutic approach are extremely rare. OBJECTIVE:The aim of this study was to estimate the co...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.2165/11588980-000000000-00000
更新日期：2011-10-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:Vedolizumab, a humanized monoclonal antibody against the α4β7 integrin, is indicated for treatment of moderately to severely active ulcerative colitis or Crohn's disease. In this placebo-controlled, double-blind, randomized, single ascending-dose study, the pharmacokinetics, pharmacodynamics, ...
journal_title：Clinical drug investigation
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40261-016-0437-4
更新日期：2016-11-01 00:00:00
abstract：:Cefoperazone is a third-generation cefalosporin that contains the N-methyl- thio-tetrazole (NMTT) side chain, which inhibits vitamin K-dependent carboxylation. Administration of NMTT-containing cefalosporins can cause alterations in the hepatic glutathione redox state, resulting in a dose-related increase in oxidised ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.2165/00044011-200626080-00006
更新日期：2006-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:The hematological side effects associated with mycophenolic acid (MPA) are relatively common and have severe consequences. The majority of literature data have not shown clear consistency in the MPA exposure-neutropenia relationship. We hypothesized that (i) adult de novo kidney transplant rec...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-018-0694-5
更新日期：2018-11-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Gemigliptin is a novel dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. This study evaluated possible pharmacodynamic and pharmacokinetic interactions between gemigliptin and metformin and investigated their tolerability. METHODS:A randomized, open-la...
journal_title：Clinical drug investigation
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40261-014-0184-3
更新日期：2014-06-01 00:00:00
abstract：INTRODUCTION:More and more evidence suggests that the density of calcification plays an important role in the plaque stability. However, few studies have investigated the statin treatment on the density of plaque calcification in patients with both coronary artery disease (CAD) and type 2 diabetes mellitus. METHODS:On...
journal_title：Clinical drug investigation
pub_type： 临床试验,杂志文章
doi：10.1007/s40261-016-0445-4
更新日期：2016-12-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:Fentanyl buccal soluble film (FBSF) is a small, bilayered, water-soluble polymer film (BioErodible MucoAdhesive; BEMA™) that adheres to the buccal mucosa and rapidly delivers fentanyl into the systemic circulation. It is approved for the treatment of cancer breakthrough pain in adult opioid-to...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.2165/11594670-000000000-00000
更新日期：2012-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:There is a risk that disturbances of activities of daily living (ADL) due to rheumatoid arthritis (RA) are increased by the occurrence of fractures, including vertebral compression fractures and femoral neck fractures, in RA patients receiving oral corticosteroid therapy. Bisphosphonates are mo...
journal_title：Clinical drug investigation
pub_type： 杂志文章,随机对照试验
doi：10.2165/00044011-200828030-00002
更新日期：2008-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:Ramucirumab is a fully immunoglobulin G (lgG) monoclonal antibody targeting vascular endothelial growth factor receptor type 2 (VEGFR2). Previous clinical trials suggested ramucirumab could improve the survival and increase the risk of adverse effects. Here, we aimed to assess the efficacy and...
journal_title：Clinical drug investigation
pub_type： 杂志文章,meta分析,评审
doi：10.1007/s40261-015-0355-x
更新日期：2016-01-01 00:00:00
abstract：:Cytochrome P450 (CYP) 3A4 has been considered to be the most important enzyme system for metabolism of lopinavir/ritonavir (LPV/r), a widely used HIV protease inhibitor (PI) recommended during pregnancy. Herein we present a clinical case of a pregnant HIV-infected woman who was taking standard doses of LPV/r, 400/100 ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-014-0245-7
更新日期：2015-01-01 00:00:00
abstract：BACKGROUND:Warfarin is a commonly used oral anticoagulant and its interaction with other drugs can result in serious thrombotic or bleeding events. Currently, there is no definitive evidence on the possibility of an interaction between warfarin and oseltamivir. OBJECTIVE:The objective of this study was to investigate ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.2165/11595860-000000000-00000
更新日期：2012-02-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:Warfarin-related nephropathy is an unexplained acute kidney injury, and may occur in patients with supratherapeutic INR, in the absence of overt bleeding. Similar findings have been observed in rats treated with dabigatran etexilate. We conducted a prospective study in dabigatran etexilate-tre...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-018-0742-1
更新日期：2019-04-01 00:00:00
abstract：:The original version of this article unfortunately contained a mistake. The corresponding author was incorrect. ...
journal_title：Clinical drug investigation
pub_type： 已发布勘误
doi：10.1007/s40261-019-00817-1
更新日期：2019-07-01 00:00:00
abstract：:None of the available antiemetics is entirely effective, perhaps because most of them act through the blockade of one receptor. There is a possibility that a combination of antiemetics with different sites of activity would be more effective than one drug alone for prophylaxis against postoperative nausea and vomiting...
journal_title：Clinical drug investigation
pub_type： 杂志文章,收录出版,评审
doi：10.2165/00044011-200222090-00001
更新日期：2002-09-01 00:00:00
abstract：BACKGROUND:The Benign Prostatic Hyperplasia-Patient Impact Measure (BPH-PIM) is a self-reported quality-of-life questionnaire for measuring the impact of urinary/prostate symptoms on the quality of life of patients with BPH. The aim of the present study was to adapt the original instrument to Spanish (for use in Spain)...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.2165/00044011-200626020-00005
更新日期：2006-01-01 00:00:00
abstract：:Page 806, column 1, line 3: The text, which previously read. ...
journal_title：Clinical drug investigation
pub_type： 已发布勘误
doi：10.1007/s40261-020-00892-9
更新日期：2020-03-01 00:00:00
abstract：BACKGROUND:Elderly patients are more susceptible to Clostridium difficile infections (CDIs). Despite existing guidelines, there is no specific treatment for CDI in geriatrics. Vancomycin is commonly used in the treatment of CDI. Teicoplanin is an alternative glycopeptide which recently received marketing authorization ...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-017-0524-1
更新日期：2017-07-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:The time-course when changes in glycemic control and body weight were first manifest in patients with type 2 diabetes mellitus (T2DM) treated with a combination of insulin degludec and liraglutide (IDegLira) was assessed, comparing IDegLira to its individual components. METHODS:Data from week...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-016-0376-0
更新日期：2016-04-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Cerebral vasospasm is a common and serious complication of aneurysmal subarachnoid haemorrhage (SAH). Many studies have revealed a role of inflammation in the development of cerebral vasospasm. This study aimed to investigate whether topically administered dexamethasone could attenuate vasospas...
journal_title：Clinical drug investigation
pub_type： 临床试验,杂志文章
doi：10.2165/00044011-200727120-00004
更新日期：2007-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:The standard of care for HIV treatment is a three-drug regimen consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either a non-nucleoside reverse transcriptase inhibitor, a protease inhibitor (PI) or an integrase strand transfer inhibitor. Darunavir boosted with ritonavi...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-016-0456-1
更新日期：2017-01-01 00:00:00
abstract：BACKGROUND:Recent data suggest that P-glycoprotein may be involved in cellular transport of lacosamide. OBJECTIVE:To investigate potential drug-drug interactions (DDIs) between lacosamide and digoxin, this phase I, multiple-dose, randomised, double-blind, placebo-controlled, crossover trial assessed the pharmacokineti...
journal_title：Clinical drug investigation
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40261-014-0180-7
更新日期：2014-05-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:The use of fibrinogen concentrate to treat or prevent major bleeding with regard to potential adverse reactions has not been free of controversy. Our objective was to perform a post-authorization safety study to describe the use of Clottafact® (LFB Biomedicaments) fibrinogen concentrate in real...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-020-00906-6
更新日期：2020-05-01 00:00:00
abstract：BACKGROUND:Aliskiren is the first oral direct renin inhibitor to be approved for the treatment of hypertension. The pharmacokinetic and pharmacodynamic profile of aliskiren has been extensively characterized in Caucasian individuals; however, drug disposition, treatment response and tolerability can vary among ethnic g...
journal_title：Clinical drug investigation
pub_type： 杂志文章,随机对照试验
doi：10.2165/11533050-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:The new oral anticoagulants (NOACs) are used for the prevention of thromboembolic complications in patients with non-valvular atrial fibrillation (AF) and those at risk of deep venous thrombosis. Their rapid onset of action and predictable pharmacokinetic and pharmacodynamic profiles make them...
journal_title：Clinical drug investigation
pub_type： 杂志文章
doi：10.1007/s40261-016-0436-5
更新日期：2016-10-01 00:00:00
